4593.T
HEALIOS K.K.
グロース · 医薬品 · 医薬品 · JP
JPY 293.00
−0.68%Price chart
Aug 5Aug 10Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−9.1x
Market Cap
JPY 29.92B
MomentumView details →
1D Return
−0.68%
YTD Return
+2.55%
RSI (14)
52.8
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−9.1x
Market Cap
JPY 29.92B
RSI (14)
52.8
MomentumView details →
1D Return
−0.68%
YTD Return
+2.55%
Similar companies
Latest newsMore news →
Helios obtained a 'regenerative medicine product manufacturing and sales license' from the Hyogo Prefectural Governor.4d agoHealios announced that its low-immunogenicity iPS cell product 'Healios UDC' obtained a patent in China.16d agoHealios announced its consolidated results for the second quarter of fiscal year 2026 (January-June 2026), reporting revenue of 0.15 billion yen, down 74.9% year-on-year, an operating loss of 24.04 billion yen, a pretax loss of 22.78 billion yen, and a net loss attributable to owners of the parent of 22.86 billion yen.23d ago